Skip to main content
Alan Leichtman, MD, Nephrology, Ann Arbor, MI

AlanBLeichtmanMD

Nephrology Ann Arbor, MI

Professor, Internal Medicine, University of Michigan Medical School

Dr. Leichtman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Leichtman's full profile

Already have an account?

  • Office

    1500 E Medical Center Dr
    # 3
    Ann Arbor, MI 48109
    Phone+1 734-936-5548

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Nephrology, 1983 - 1987
  • Ascension Providence/MSUCHM
    Ascension Providence/MSUCHMResidency, Internal Medicine, 1979 - 1982
  • Ascension Providence/MSUCHM
    Ascension Providence/MSUCHMInternship, Transitional Year, 1978 - 1979
  • Michigan State University College of Human Medicine
    Michigan State University College of Human MedicineClass of 1978

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1981 - 2019

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Grant Support

  • Pharmacokinetic, Safety &Tolerability Of FTY720 In Stable Renal Transplant PatieNational Center For Research Resources2000–2002
  • Efficacy &Safety Of SDZ RAD Immunosuppressive Therapy In Renal TransplantsNational Center For Research Resources2000–2002
  • Sirolimus Azathioprine With Immunosuppressive Therapy In Allograft RecipientsNational Center For Research Resources1998–2000
  • Sandimmune In Stable Renal Transplant Patients WHO Absorb Cyclosporine PoorlyNational Center For Research Resources1998–1999
  • Intravenous SB 209670 To Prevent Radiocontrast Induced Acute Renal FailureNational Center For Research Resources1998–1999
  • Neoral (TM) In Stable Renal Transplant PatientsNational Center For Research Resources1997
  • Acute Renal Graft Rejection W/ Bmy-42215-1 (15-Deoxyspergualin Trihydrochloride)National Center For Research Resources1997
  • Tolerability Of Neoral In Stable Renal Transplant PatientsNational Center For Research Resources1996
  • Sandimmune And Og37 325 In Prevention Of Renal Allograft RejectionNational Center For Research Resources1996
  • Og37 325 VS Sandimmune Oral Solutions In Renal Allograft RecipientsNational Center For Research Resources1996